Cox univariate survival analysis indicated that prognosis was influenced by lymph node metastasis (p = 0.002), tumor location (p = 0.02), clinical stage (p = 0.0007), and GPX4 expression. This evidence concerns the gene GPX4 and metastatic malignant neoplasm in the lymph nodes.